Drug Profile
DFD 05
Alternative Names: DFD05Latest Information Update: 22 Aug 2019
Price :
$50
*
At a glance
- Originator Promius Pharma
- Class Antivirals; Skin disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Warts
Most Recent Events
- 22 Aug 2019 Discontinued - Phase-II for Warts in USA (Topical)
- 01 Aug 2016 Promius Pharma completes phase-II clinical trials in Warts in USA (Topical) (NCT02798419)
- 01 Jan 2016 Phase-II clinical trials in Warts in USA (Topical)